
Invest in the nuclear renaissance through our list of 90 elite nuclear energy infrastructure plays powering the global AI revolution.
To own Knowles, you need to believe its medtech, industrial, and defense exposure plus expanding capacitor and inductor lines can support steady, profitable growth. The upcoming earnings are a key short term catalyst because expectations are anchored on continued outperformance, while the main risk is that margin pressure from mix and factory costs resurfaces. This week’s setup heightens that tension but does not materially change the core thesis on its own.
Among recent announcements, the June expansion of Knowles’s high performance capacitor portfolio looks most relevant. It ties directly to the idea that new specialty film and ceramic products can broaden the addressable market and help offset modest organic growth. How effectively these new capacitors gain traction will matter for both revenue visibility and the company’s ability to counter any ongoing margin and cost risks.
Yet despite this recent strength, investors should also weigh how vulnerable Knowles could be if a concentrated customer base were to suddenly...
Read the full narrative on Knowles (it's free!)
Knowles’ narrative projects $741.0 million revenue and $120.2 million earnings by 2029. This requires 6.5% yearly revenue growth and about a $57.6 million earnings increase from $62.6 million today.
Uncover how Knowles' forecasts yield a $36.25 fair value, in line with its current price.
Some of the lowest analysts were already cautious, assuming revenue around US$746.4 million and earnings near US$124.3 million by 2029, and their concern about customer concentration shows how differently you and they might weigh this week’s earnings surprise.
Explore 2 other fair value estimates on Knowles - why the stock might be worth as much as 7% more than the current price!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com